Importance of drug transporters in pharmacokinetics and drug safety

被引：6

作者：

Ward, Peter ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, DMPK Dept, San Diego, CA 92121 USA

来源：

TOXICOLOGY MECHANISMS AND METHODS | 2008年 / 18卷 / 01期

关键词：

transporters; drug-drug interactions; drug elimination; toxicity; pharmacology; pharmacokinetics; P-glycoprotein;

D O I：

10.1080/15376510701795306

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

The exact role of transporters in the absorption, distribution, and excretion (ADE) of drugs is still being elucidated; however, current evidence suggests that their role in these processes may be significant. In this review, the role of transporters in the ADE, pharmacology, toxicology, and clinical drug-drug interactions (DDIs) of drugs will be discussed. The current biological tools to assess this role and practical perspectives for the utilization of knowledge about drug transporters to drug discovery and development will also be discussed. Currently, regulatory agencies are focusing on these potential transporter-mediated DDIs. Therefore, guidance and caution on the investigation of these DDIs will be given.

引用

页码：1 / 10

页数：10

共 50 条

[21] Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance [J].

Zamek-Gliszczynski, Maciej J. ;

Taub, Mitchell E. ;

Chothe, Paresh P. ;

Chu, Xiaoyan ;

Giacomini, Kathleen M. ;

Kim, Richard B. ;

Ray, Adrian S. ;

Stocker, Sophie L. ;

Unadkat, Jashvant D. ;

Wittwer, Matthias B. ;

Xia, Cindy ;

Yee, Sook-Wah ;

Zhang, Lei ;

Zhang, Yan .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) :890-899

[22] Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox [J].

Lacroix, Clemence ;

Guilhaumou, Romain ;

Micallef, Joelle ;

Blin, Olivier .

THERAPIE, 2024, 79 (03) :351-363

[23] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions [J].

Vazquez, Marta ;

Garcia-Carnelli, Carlos ;

Maldonado, Cecilia ;

Fagiolino, Pietro .

CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 :27-42

[24] ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development [J].

Choi, Young Hee ;

Yu, Ai-Ming .

CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (05) :793-807

[25] The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development [J].

Moore, Kenneth T. ;

Zannikos, Peter N. ;

Masters, Joanna C. ;

Willmann, Stefan ;

Shen, Jinshan ;

Frost, Charles .

JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 :S78-S84

[26] Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics [J].

Fardel, Olivier ;

Kolasa, Elise ;

Le Vee, Marc .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (01) :29-46

[27] Pharmacokinetics, Drug Metabolism, and Safety of Prasugrel and Clopidogrel [J].

Achar, Suraj .

POSTGRADUATE MEDICINE, 2011, 123 (01) :73-79

[28] Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes [J].

Mariappan, T. Thanga ;

Shen, Hong ;

Marathe, Punit .

CURRENT DRUG METABOLISM, 2017, 18 (08) :757-768

[29] Multidrug transporters as drug targets [J].

Liang, X. -J. ;

Aszalos, A. .

CURRENT DRUG TARGETS, 2006, 7 (08) :911-921

[30] Role of Transporters in Drug Development [J].

Arya, Vikram ;

Kiser, Jennifer J. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 :S7-S10

← 1 2 3 4 5 →